Physiopathological link between polycystic ovary syndrome and hyperprolactinemia: Myth or reality?;Lien physiopathologique entre syndrome des ovaires polymicrokystiques et hyperprolactinémie: Mythe ou réalité?

Gynecologie Obstetrique et Fertilite

Volumn 39, Issue 3, 2011, Pages 141-145

  Robin, Geoffroy ^a   Catteau Jonard, Sophie ^a   Young, Jacques ^b   Dewailly, Didier ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

Hyperandrogenism; Hyperprolactinemia; Macroprolactinemia; Menstrual disorders; Polycystic ovary syndrome

Indexed keywords

GONADOTROPIN; PROLACTIN;

ARTICLE; FEMALE; HUMAN; HYPERPROLACTINEMIA; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PROLACTIN BLOOD LEVEL; ULTRASOUND;

EID: 79952987544     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2010.11.002     Document Type: Article

References (38)

1. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19(1):41-7.
2. R. Azziz The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report Fertil Steril 91 2 2009 456 488
3. R.J. Norman Polycystic ovary syndrome Lancet 370 9588 2007 685 697 (Pubitemid 47285318)
4. C. Cortet-Rudelli Etiological diagnosis of hyperprolactinemia Ann Endocrinol (Paris) 68 2-3 2007 98 105
5. T. Brue, and B. Delemer Diagnosis and management of hyperprolactinemia: expert consensus - French Society of Endocrinology Ann Endocrinol (Paris) 68 1 2007 58 64 (Pubitemid 46616591)
6. E. Carmina Prolactin secretion in polycystic ovary syndrome (PCO): correlation with the steroid pattern Acta Endocrinol (Copenh) 105 1 1984 99 104 (Pubitemid 14214294)
7. N. Bracero, and H.A. Zacur Polycystic ovary syndrome and hyperprolactinemia Obstet Gynecol Clin North Am 28 1 2001 77 84 (Pubitemid 32242541)
8. A.A. Luciano, F.K. Chapler, and B.M. Sherman Hyperprolactinemia in polycystic ovary syndrome Fertil Steril 41 5 1984 719 725 (Pubitemid 14102134)
9. A.P. Murdoch, W. Dunlop, and P. Kendall-Taylor Studies of prolactin secretion in polycystic ovary syndrome Clin Endocrinol (Oxf) 24 2 1986 165 175 (Pubitemid 16160982)
10. H. Minakami Prolactin release in polycystic ovarian syndrome Endocrinol Jpn 35 2 1988 303 310 (Pubitemid 19006060)
11. R.B. Filho Polycystic ovary syndrome and hyperprolactinemia are distinct entities Gynecol Endocrinol 23 5 2007 267 272 (Pubitemid 46897698)
12. W. Futterweit, and D.T. Krieger Pituitary tumors associated with hyperprolactinemia and polycystic ovarian disease Fertil Steril 31 6 1979 608 613 (Pubitemid 9166599)
13. J. Reese Implantation and decidualization defects in prolactin receptor (PRLR)-deficient mice are mediated by ovarian but not uterine PRLR Endocrinology 141 5 2000 1872 1881 (Pubitemid 32274417)
14. S.M. Plosker Opioid, catecholamine, and steroid interaction in prolactin and gonadotropin regulation Obstet Gynecol Surv 45 7 1990 441 453 (Pubitemid 20246104)
15. J. Buvat A double blind controlled study of the hormonal and clinical effects of bromocriptine in the polycystic ovary syndrome J Clin Endocrinol Metab 63 1 1986 119 124 (Pubitemid 16093018)
16. R.B. Barnes Effects of dopamine and metoclopramide in polycystic ovary syndrome J Clin Endocrinol Metab 63 2 1986 506 509 (Pubitemid 16035705)
17. S.S. Yen Neuroendocrinology of opioid peptides and their role in the control of gonadotropin and prolactin secretion Am J Obstet Gynecol 152 4 1985 485 493 (Pubitemid 15003120)
18. Robin G, et al. Le syndrome des ovaires polymicrokystiques. EMC (Elsevier Masson SAS, Paris), Endocrinologie-Nutrition, 10-027-C-10, 2007.
19. C.A. Eagleson Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone J Clin Endocrinol Metab 85 11 2000 4047 4052 (Pubitemid 32055351)
20. S. Christin-Maitre Prolactinoma and estrogens: pregnancy, contraception and hormonal replacement therapy Ann Endocrinol (Paris) 68 2-3 2007 106 112 (Pubitemid 47241115)
21. R.A. Yazigi, C.H. Quintero, and W.A. Salameh Prolactin disorders Fertil Steril 67 2 1997 215 225 (Pubitemid 27052174)
22. Castinetti F, Brue T. Hyperprolactinémie : diagnostic. Med Clin Endocrinol Diabet 2006:19-22 (Hors série Sept 2006).
23. I.S. Fraser, and G. Kovacs Current recommendations for the diagnostic evaluation and follow-up of patients presenting with symptomatic polycystic ovary syndrome Best Pract Res Clin Obstet Gynaecol 18 5 2004 813 823 (Pubitemid 40424613)
24. E. Dahlgren Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones Fertil Steril 57 3 1992 505 513
25. A. Szilagyi Changes in circulating hormone levels after ovarian wedge resection in patients with polycystic ovary syndrome Arch Gynecol Obstet 248 1 1990 31 35 (Pubitemid 20325759)
26. A. Szilagyi Effects of ovarian surgery on the dopaminergic and opioidergic control of gonadotropin and prolactin secretion in women with polycystic ovarian disease Gynecol Endocrinol 7 3 1993 159 166 (Pubitemid 23341595)
27. J.M. Nolin Does androgen influence prolactin secretion? Endocr Res Commun 4 1 1977 61 70 (Pubitemid 8101670)
28. R. D'Agata Effect of androgens on prolactin (PRL) release in humans Acta Endocrinol (Copenh) 90 3 1979 409 413 (Pubitemid 9141954)
29. J.E. Hall Insights into hypothalamic-pituitary dysfunction in polycystic ovary syndrome J Endocrinol Invest 21 9 1998 602 611 (Pubitemid 28532467)
30. M. Ruberg Regulation of prolactin secretion at the pituitary level Exp Brain Res Suppl 3 1981 182 199 (Pubitemid 11094672)
31. P. Acien, M. Mauri, and M. Gutierrez Clinical and hormonal effects of the combination gonadotrophin-releasing hormone agonist plus oral contraceptive pills containing ethinyl-oestradiol (EE) and cyproterone acetate (CPA) versus the EE-CPA pill alone on polycystic ovarian disease-related hyperandrogenisms Hum Reprod 12 3 1997 423 429 (Pubitemid 27156429)
32. M. Bazot Ovarian functional disorders J Radiol 81(12 Suppl) 2000 1801 1818
33. J. Phy Transvaginal ultrasound detection of multifollicular ovaries in non-hirsute ovulatory women Ultrasound Obstet Gynecol 23 2 2004 183 187 (Pubitemid 38221795)
34. J.N. Carter Adrenocortical function in hyperprolactinemic women J Clin Endocrinol Metab 45 5 1977 973 980 (Pubitemid 8238610)
35. K. Higuchi Prolactin has a direct effect on adrenal androgen secretion J Clin Endocrinol Metab 59 4 1984 714 718 (Pubitemid 14012496)
36. R.J. Schiebinger The effect of serum prolactin on plasma adrenal androgens and the production and metabolic clearance rate of dehydroepiandrosterone sulfate in normal and hyperprolactinemic subjects J Clin Endocrinol Metab 62 1 1986 202 209 (Pubitemid 16186867)
37. H.F. Escobar-Morreale Macroprolactinemia in women presenting with hyperandrogenic symptoms: implications for the management of polycystic ovary syndrome Fertil Steril 82 6 2004 1697 1699 (Pubitemid 39611409)
38. A.M. Suliman Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia Clin Chem 49 9 2003 1504 1509 (Pubitemid 37011739)